Miapaca2（人胰腺癌腫瘤細(xì)胞）
CBP60544
詢 價(jià)
索取STR
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫(kù)
| I. General information | |
| Synonyms: | Miapaca2 |
| Background: | The MIA PaCa-2 cell line was established by A. Yunis, et al. in 1975 from tumor tissue of the pancreas obtained from a 65-year-old Caucasian male. Hybridomas have been made against the CSF-I produced by this line ATCC HB-8207 (F1A3-23) and ATCC HB-8208 (F18 AF1). |
| Species: | Homo sapiens, human |
| Tissue: | pancreas |
| Disease: | carcinoma |
| Gender: | Caucasian,male,65 years |
| Morphology: | attached epithelial with floating rounded cells |
| Growth Mode: | attached epithelial with floating rounded cells |
| DNA Profile: | Amelogenin: X CSF1PO: 10 D13S317: 12,13 D16S539: 10,13 D5S818: 12,13 D7S820: 12,13 THO1: 9,10 TPOX: 9 vWA: 15 Our Cell Line Authentication Service |
| Culture Medium: |
DMEM+10%FBS+5% horse serum Miapaca2完全培養(yǎng)基，# CBP60544M |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Genes Expressed: | human colony stimulating factor, subclass I (CSF-I); plasminogen activator |
| Cellular Products: | human colony stimulating factor, subclass I (CSF-I); plasminogen activator |
| Comments: | Certificates of Analysis are available electr onically atwww.atcc.org, or by hardcopy upon request. Certified Reference Material produced under an ISO Guide 34:2009 accredited process. Item has been tested for KRAS mutation (p.G12C c.34G>T),The established cell line reportedly has a doubling time of about 40 hours and a colony-forming efficiency in soft agar of approximately 19%. The line is sensitive to asparaginase. For more information, please contact us (4008-750-250). |
